"Venn, a provider of clinical trial management services to pharmaceutical, biotech and medical device companies, said last week it had signed new contracts worth over €3.4 million with a leading unnamed US-based biotechnology client."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.